Cepheid Sells Pathogen Detection Systems to FDA | GenomeWeb

NEW YORK, Sept. 8 (GenomeWeb News) - Cepheid said today that it has received an order for 16 of its Smart Cycler II starter systems from the FDA for general use in food safety testing.

Financial terms of the deal were not disclosed.

Sunnyvale, Calif.-based Cepheid said roughly 60 percent of state public health institutions use Smart Cycler systems for pathogen detection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.